A Retrospective Combination Health Outcomes Study among Diabetic Patients with Chronic Kidney Disease: A Multi-Level Study

Authors

  • Pirin Nichachotesalid Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Bangkok 10210, Thailand
  • Nantiya Watthayu Faculty of Nursing, Mahidol University, Bangkok 10700, Thailand
  • Siriorn Sindhu Faculty of Nursing, Mahidol University, Bangkok 10700, Thailand
  • Chukiat Viwatwongkasem Department of Biostatistics, Faculty of Public Health, Mahidol University, Bangkok 10700, Thailand

DOI:

https://doi.org/10.48048/tis.2022.3223

Keywords:

Glycemic control, Chronic kidney disease progression, Integrated care, Diabetes selfcare activities, Multi-level

Abstract

Diabetes is the prominent cause of the progression of chronic kidney diseases (CKD) worldwide. Effective implementation of healthcare services and healthcare delivery system to control glycemic level and slow annually declining eGFR remain a challenge in many countries including Thailand. The aims of this study were to investigate the association between individual and health service delivery factors on the combination health outcomes. This multi-level study applied case-control method was conducted. The 397 participants were recruited from 11 hospitals during December 2018 to May 2019 in Thailand. The samples were categorized into 4-group combination health outcome. Data analysis was performed by descriptive analysis and multi-level multinomial logistic regression analysis. The multinomial logistic regression in bivariate analysis showed that diabetes self-care activities score were more likely to control glycemic and CKD progression compared with those with a low-level of DSCA (OR 3.47; 95 % CI: 1.19 - 10.15). The rational drug uses (RDU) as the health service-level factors increased combination health outcomes 2 times (OR 2.41; 95 % CI: 1.05 - 5.53). The multi-level analysis found that performing with high-level of DSCA (OR 5.36; 95 % CI :1.99 - 14.46) and rational drug uses of metformin and NSAIDs (OR 2.33; 95 % CI: 1.25 - 4.36) increased probability to achieve combination health outcomes. Findings highlight the importance of diabetes self-care activities and health service delivery system to optimize the combination health outcomes among diabetic patients with CKD.

HIGHLIGHTS

  • The glycemic control and slow kidney disease progression could decrease diabetic complications
  • The challenges of complicate diseases management involved patient-level and health service-level factors
  • The high-level of DSCA showed the significant association with glycemic control and slow kidney disease progression
  • This study encourages professional nurses promote the model of care that appropriate for individual person who had the difference of age, BMI and self-care activities level


GRAPHICAL ABSTRACT

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

IN Migdalis, N Papanas, AE Raptis, IM Ioannidis, AE Sotiropoulos and GD Dimitriadis. The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: A series from hospital-based diabetes clinics. Diabetes Res. Clin. Pract. 2020; 166, 108243.

DN Koye, DJ Magliano, RG Nelson and ME Pavkov. The global epidemiology of diabetes and kidney disease. Adv Chron. Kidney Dis. 2018; 25, 121-32.

MC Thomas, ME Cooper and P Zimmet. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat. Rev. Nephrol. 2016; 12, 73-81.

J Jitraknatee, C Ruengorn and S Nochaiwong. Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: A cross-sectional study in primary care practice. Sci. Rep. 2020; 10, 6205.

CW Tsai, IW Ting, HC Yeh and CC Kuo. Longitudinal change in estimated GFR among CKD patients: A 10-year follow-up study of an integrated kidney disease care program in Taiwan. PLoS One 2017; 12, e0173843.

GMR Goncalves and EN Silva. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System. PLoS One 2018; 13, e0203992.

V Agrawal, C Giri and R Solomon. The effects of glucose-lowering therapies on diabetic kidney disease. Curr. Diabetes Rev. 2015; 11, 191-200.

E Zimbudzi, C Lo, ML Misso, S Ranasinha, PG Kerr, HJ Teede and S Zoungas. Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: A systematic review and meta-analysis. Syst. Rev. 2018; 7, 84.

LA Inker, BC Astor, CH Fox, T Isakova, JP Lash, CA Peralta, MK Tamura and HI Feldman. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am. J. Kidney. Dis. 2014; 63, 713-35.

W Aekplakorn, S Chariyalertsak, P Kessomboon, S Assanangkornchai, S Taneepanichskul and P Putwatana. Prevalence of diabetes and relationship with socioeconomic status in the Thai population: National health examination survey, 2004-2014. J. Diabetes Res. 2018; 2018, 1654530.

B Satirapoj and SG Adler. Comprehensive approach to diabetic nephropathy. Kidney Res. Clin. Pract. 2014; 33, 121-31.

T Yotsapon, K Sirinate, W Ekgaluck, V Somboon, A Tawee, K Worawit, N Soontaree and H Thep. Clinical characteristics and outcomes of the oldest old people with type 2 diabetes - perspective from a tertiary diabetes center in Thailand. BMC Endocr. Disord. 2016; 16, 30.

A Mantovani, G Grani, L Chioma, G Vancieri, I Giordani, R Rendina, ME Rinaldi, A Andreadi, C Coccaro, C Boccardo, C Fraenza, G Bertazzoni, A Bellia, G Zoppini, G Targher, MG Baroni, D Lauro, M D'Armiento and E Bonora. Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study. J. Clin. Translat. Endocrinol. 2016; 5, 46-52.

T Iwai, M Miyazaki, G Yamada, M Nakayama, T Yamamoto, M Satoh and S Ito. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: The Gonryo study. Clin. Exp. Nephrol. 2018; 22, 328-36.

P Vejakama, A Ingsathit, J Attia and A Thakkinstian. Epidemiological study of chronic kidney disease progression: A large-scale population-based cohort study. Medicine 2015; 94, e475.

R Timar, I Velea, B Timar, D Lungeanu, C Oancea, D Roman and O Mazilu. Factors influencing the quality of life perception in patients with type 2 diabetes mellitus. Patient Preference Adherence 2016; 10, 2471-7.

TTH Dinh, A Bonner, R Clark, J Ramsbotham and S Hines. The effectiveness of the teach-back method on adherence and self-management in health education for people with chronic disease: A systematic review. JBI Database Syst. Rev. Implementation Rep. 2016; 14, 210-47.

S Reutrakul and C Deerochanawong. Diabetes in Thailand: Status and policy. Curr. Diabetes Rep. 2016; 16, 28.

SY Chen, YC Lee, V Alas, M Greene and D Brixner. Outcomes associated with nonconcordance to National Kidney Foundation guideline recommendations for oral antidiabetic drug treatments in patients with concomitant type 2 diabetes and chronic kidney disease. Endocr. Pract. 2014; 20, 221- 31.

T Zhou, X Xu, M Du, T Zhao and J Wang. A preclinical overview of metformin for the treatment of type 2 diabetes. Biomed. Pharmacother. 2018; 106, 1227-35.

N Helou, A Dwyer, M Shaha and A Zanchi. Multidisciplinary management of diabetic kidney disease: A systematic review and meta-analysis. JBI Database Syst. Rev. Implementation Rep. 2016; 14, 169-207.

SA Watts and A Sood. Diabetes nurse case management: Improving glucose control: 10 years of quality improvement follow-up data. Appl. Nurs. Res. 2016; 29, 202-5.

A Albai, A Sima, I Papava, D Roman, B Andor and M Gafencu. Association between coping mechanisms and adherence to diabetes-related self-care activities: A cross-sectional study. Patient Preference Adherence 2017; 11, 1235-41.

K Kilpatrick, V Pichette and M Jabbour. An interprofessional team that includes a nurse practitioner and patients with diabetes and chronic kidney disease. J. ACITN 2014; 24, 11-8.

C Lo, H Teede, D Ilic, G Russell, K Murphy, T Usherwood, S Ranasinha and S Zoungas. Identifying health service barriers in the management of co-morbid diabetes and chronic kidney disease in primary care: A mixed-methods exploration. Fam. Pract. 2016; 33, 492-7.

IG Okpechi, AK Bello, OI Ameh and CR Swanepoel. Integration of care in management of CKD in resource-limited settings. Semin. Nephrol. 2017; 37, 260-72.

KK Clemens, V Kalatharan, BL Ryan and S Reichert. Nonconventional diabetes-related care strategies for patients with chronic kidney disease: A scoping review of the literature. J. Comorbidity 2019; 9, 1-14.

E Zimbudzi, C Lo, S Ranasinha, H Teede, T Usherwood, KR Polkinghorne, G Fulcher, M Gallagher, S Jan, A Cass, R Walker, G Russell, G Johnson, PG Kerr and S Zoungas. Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: A longitudinal study. BMJ Open Diabetes Res. Care 2020; 8, e000842.

ME Charlson, P Pompei, KL Ales and CR MacKenzie. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chron. Dis. 1987; 40, 373-83.

DJ Toobert, SE Hampson and RE Glasgow. The summary of diabetes self-care activities measure: Results from 7 studies and a revised scale. Diabetes Care 2000; 23, 943-50.

M Atif, M Qamar-Uz-Zaman, MR Sarwar and M Azeem. PHP35: Assessment of core drug use indicators using WHO/INRUD methodology at primary health care centers in Bahawalpur, Pakistan. Value Health 2016; 19, A445.

C Kwak and A Clayton-Matthews. Multinomial logistic regression. Nurs. Res. 2002; 51, 404-10.

P Arora, K Jalal, A Gupta, RL Carter and JW Lohr. Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients. Int. Urol. Nephrol. 2017; 49, 1033-40.

B Satirapoj and SG Adler. Comprehensive approach to diabetic nephropathy. Kidney Res. Clin. Pract. 2014; 33, 121-31.

HR Yun, H Kim, JT Park, TI Chang, TH Yoo, SW Kang, KH Choi, S Sung, SW Kim, J Lee, KH Oh, C Ahn and SH Han. Obesity, metabolic abnormality, and progression of CKD. Am. J. Kidney Dis. 2018; 72, 400-10.

M Alsahli and JE Gerich. Hypoglycemia, chronic kidney disease, and diabetes mellitus. Mayo Clin. Proc. 2014; 89, 1564-71.

E Gerdts and V Regitz-Zagrosek. Sex differences in cardiometabolic disorders. Nat. Med. 2019; 25, 1657-66.

Y Dong, P Wang, Z Dai, K Liu, Y Jin, A Li, S Wang and J Zheng. Increased self-care activities and glycemic control rate in relation to health education via Wechat among diabetes patients: A randomized clinical trial. Medicine 2018; 97, e13632.

DM Zelle, G Klaassen, E van Adrichem, SJL Bakker, E Corpeleijn and G Navis. Physical inactivity: A risk factor and target for intervention in renal care. Nat. Rev. Nephrol. 2017; 13, 152-68.

M Tangkiatkumjai, DM Walker, K Praditpornsilpa and H Boardman. Association between medication adherence and clinical outcomes in patients with chronic kidney disease: A prospective cohort study. Clin. Exp. Nephrol. 2017; 21, 504-12.

T Yotsapon, K Sirinate, W Ekgaluck, V Somboon, A Tawee, K Worawit, N Soontaree and H Thep. Clinical characteristics and outcomes of the oldest old people with type 2 diabetes - perspective from a tertiary diabetes center in Thailand. BMC Endocr. Dis. 2016; 16, 30.

D Komwong and J Sriratanaban. Associations between structures and resources of primary care at the district level and health outcomes: A case study of diabetes mellitus care in Thailand. Risk Manag. Healthc. Pol. 2018; 11, 199-208.

DM Johnson, RS Russell and SW White. Perceptions of care quality and the effect on patient satisfaction. Inter. J. Qual. Reliab. Manag. 2016; 33, 1202-29.

SY Chen, K Siu, B Kovacs, M Stokes, P Rao, S Sander and L Boulanger. United BioSource. Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease. Curr. Med. Res. Opin. 2012; 28, 493-501.

PH Winocour. Diabetes and chronic kidney disease: An increasingly common multi-morbid disease in need of a paradigm shift in care. Diabet. Med. 2018; 35, 300-5.

SL Tummalapalli, NR Powe and S Keyhani. Trends in quality of care for patients with CKD in the United States. Clin. J. Am. Soc. Nephrol. 2019; 14, 1142-50.

X Zhang, PT Donnan, S Bell and B Guthrie. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: Systematic review and meta-analysis. BMC Nephrol. 2017; 18, 256.

E Zimbudzi, C Lo, T Robinson, S Ranasinha, HJ Teede, T Usherwood, KR Polkinghorne, PG Kerr, G Fulcher, M Gallagher, S Jan, A Cass, R Walker, G Russell, G Johnson and S Zoungas. The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study. PLoS One 2019; 14, e0219685.

R Cody, S Gysin, C Merlo, A Gemperli and S Essig. Complexity as factor for task alloaction among general practictioners: A narrative review. BMC Fam. Pract. 2020; 21, 38.

A Bonner, K Havas, V Tam, C Stone, J Abel, M Barnes and C Douglas. An integrated chronic disease nurse practitioner clinic: Service model description and patient profile. Collegian 2019; 26, 227-34.

P Väre, E Nikiphorou, P Hannonen and T Sokka. Delivering a one-stop, integrated, and patient-centered service for patients with rheumatic diseases. SAGE Open Med. 2016; 4, 1-7.

Downloads

Published

2022-03-15

How to Cite

Nichachotesalid, P. ., Watthayu, N. ., Sindhu, S. ., & Viwatwongkasem, C. . (2022). A Retrospective Combination Health Outcomes Study among Diabetic Patients with Chronic Kidney Disease: A Multi-Level Study. Trends in Sciences, 19(8), 3223. https://doi.org/10.48048/tis.2022.3223